Variable | Discharged (N = 4,303) | Died (N = 1,524) | Total (N = 5,827) | p value |
---|---|---|---|---|
Median Age (IQR) | 39(31–48) | 40(31–50) | 39 (31–49) |  |
Age group (years) (%) | Â | Â | Â | Â |
 <24 | 333 (7.74) | 101 (6.63) | 434 (7.45) | 0.053 |
 25–49 | 2,976 (69.16) | 1,029 (67.52) | 4,005 (68.73) |  |
 ≥50 | 994 (23.10) | 394 (25.85) | 1,388 (23.82) |  |
Sex | Â | Â | Â | Â |
 Female | 2,483 (57.70) | 810 (53.15) | 3,293 (56.51) | 0.002 |
 Male | 1,820 (42.30) | 714 (46.85) | 2,534 (43.49) |  |
Address | Â | Â | Â | Â |
 Distance < 10 km from the hospital | 1,720 (39.97) | 550 (36.09) | 2,270 (38.96) | 0.001 |
 Distance 10-20 km from the hospital | 1,550 (36.02) | 537 (35.24) | 2,087 (35.82) |  |
 Distance > 20 km from the hospital | 1,033 (24.01) | 437 (28.67) | 1,470 (25.23) |  |
Admission status | Â | Â | Â | Â |
 New admission | 3,790 (88.08) | 1,390 (91.21) | 5,180 (88.90) | 0.001 |
 Readmission | 513 (11.92) | 134 (8.79) | 647 (11.1) |  |
ART Status at Admission | Â | Â | Â | Â |
 Active on ART | 2,824 (65.63) | 886 (58.14) | 3,710 (63.67) | < 0.001 |
 ART Naïve | 717 (16.66) | 256 (16.80) | 973 (16.70) |  |
 ART Interruption | 762 (17.71) | 382 (25.07) | 1,144 (19.63) |  |
Median Days of Hospital Stay (IQR) | 6 (3–11) | 3 (1–7) | 5 (2–10) |  |
Median Viral Load (n = 216) | 50 (0–13,900) | 95(0-119,000) | 50(0–28,290) |  |
Median CD4 cell count (µL, IQR) | 133 (30–380) | 57 (16–197) | 109 (25–343) |  |
CD4 + cell counts |  |  |  |  |
 CD4 + ≤ 200 cells/µL | 1,624 (37.74) | 647 (42.45) | 2,271 (38.97) | < 0.001 |
 CD4 + > 201 cells/µL | 1,189 (27.63) | 255 (16.73) | 1,444 (24.78) |  |
 CD4 + Not Documented | 1,490 (34.63) | 622 (40.81) | 2,112 (36.25) |  |
Function Assessment | Â | Â | Â | Â |
 ECOG Score 1–2 | 3,175 (73.79) | 427 (28.02) | 3,602 (61.82) | < 0.001 |
 ECOG Score 3–4 | 1,128 (26.21) | 1,097 (71.98) | 2,225 (38.18) |  |
Clinical Diagnoses | Â | Â | Â | Â |
 Tuberculosis | 1,429 (33.21) | 525 (34.45) | 1,954 (33.53) | 0.378 |
 Co-infections | 910 (21.15) | 457 (29.99) | 1,367 (23.46) | < 0.001 |
 Cardiovascular disease | 757 (17.59) | 218 (14.30) | 975 (16.73) | 0.003 |
 Malnutrition | 475 (11.04) | 332 (21.78) | 807 (13.85) | < 0.001 |
 Cryptococcal Disease | 558 (12.97) | 181 (11.88) | 739 (12.68) | 0.271 |
 Anaemia | 454 (10.55) | 192 (12.60) | 646 (11.09) | 0.029 |
 Kidney Disease | 338 (7.85) | 176 (11.55) | 514 (8.82) | < 0.001 |
 Candidiasis | 331 (7.69) | 112 (7.35) | 443 (7.60) | 0.664 |
 Diabetes Mellitus | 304 (7.06) | 86 (5.64) | 390 (6.69) | 0.057 |
 Liver Disease | 214 (4.97) | 124 (8.14) | 338 (5.80) | < 0.001 |
 Neurologic disorders | 191 (4.44) | 38 (2.49) | 229 (3.93) | 0.001 |
 Chronic Lung Disease | 148 (4.04) | 37 (2.86) | 185 (3.73) | 0.053 |
 COVID-19 | 114 (2.65) | 77 (5.05) | 191 (3.28) | < 0.001 |
 Cancer | 108 (2.51) | 39 (2.56) | 147 (2.52) | 0.916 |
 Toxoplasmosis | 102 (2.37) | 40 (2.62) | 142 (2.44) | 0.580 |
 Kaposi Sarcoma | 91 (2.11) | 33 (2.17) | 124 (2.13) | 0.906 |